Effect of adriamycin on DNA, RNA, and protein synthesis in cell-free systems and intact cells.
The effect of adriamycin on DNA, RNA, and protein synthesis was investigated in cell-free systems and intact cells. In studies with purified mammalian cell enzymes, adriamycin produced a greater inhibition of DNA-dependent DNA polymerase than of RNA polymerase. The extent of inhibition of both these enzymes was decreased by increasing the concentration of the DNA template in the reaction mixture. In studies with isolated nuclei, adriamycin was also a more potent inhibitor of DNA synthesis than RNA synthesis. However, with intact cells, adriamycin inhibited both DNA and RNA synthesis to about the same extent. The inhibition produced by adriamycin on RNA synthesis in intact cells was greater than that observed in the cell-free systems. Adriamycin inhibited protein synthesis in a cell-free system consisting of polyribosomes, transfer RNA, and enzymes but did not inhibit protein synthesis in intact cells. These differences in the pattern of inhibition may be due to biotransformation of the drug and/or preferential binding to chromosomal DNA in the intact cell.
D001665:Binding Sites; D002467:Cell Nucleus / Q000378:metabolism; D002474:Cell-Free System / Q000187:drug effects; D002875:Chromosomes / Q000378:metabolism; D004254:DNA Nucleotidyltransferases / Q000037:antagonists & inhibitors; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D012321:DNA-Directed RNA Polymerases / Q000037:antagonists & inhibitors; D004317:Doxorubicin / Q000494:pharmacology*; D005354:Fibrosarcoma / Q000378:metabolism; D066298:In Vitro Techniques; D009363:Neoplasm Proteins / Q000096:biosynthesis*; D009374:Neoplasms, Experimental / Q000378:metabolism; D012334:RNA, Neoplasm / Q000096:biosynthesis*
D004273:DNA, Neoplasm; D009363:Neoplasm Proteins; D012334:RNA, Neoplasm; D004317:Doxorubicin; D004254:DNA Nucleotidyltransferases; D012321:DNA-Directed RNA Polymerases